Skip to main content

Advertisement

SpringerLink
Log in

Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tramacere I, Del Giovane C, Salanti G et al (2016) Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011381.pub2

    Article  PubMed  Google Scholar 

  2. Edelstein P Roy C (2015) Legionnaire’s disease and pontiac fever. In: Bennett J, Dolin R, Blaser M Mandell, Douglas, Bennett’s (8th ed): Principles and practices of infectious diseases. Elsevier, Philadelphia pp 2633–2644.

  3. Mills E, Ogrodnik M, Plave A et al (2018) Emerging understanding of the mechanism of action of dimethyl fumarate in the treatment of multiple sclerosis. Frontiers Neurol 23(9):5. https://doi.org/10.3389/fneur.2018.00005

    Article  Google Scholar 

  4. Burillo A, Pedro-Botet ML, Bouza E (2017) Microbiology and Epidemiology of Legionnaire’s Disease. Infect Dis Clin North Am 31(1):7–27. https://doi.org/10.1016/j.idc.2016.10.002

    Article  PubMed  Google Scholar 

  5. Brandstadter R et al. (2017) A case of Legionnaires' disease in a patient on dimethyl fumarate therapy for relapsing-remitting multiple sclerosis. Mult Scler J 23(Suppl. 1):871–872. https://doi.org/10.1177/1352458517731285 (Abstract EP1656, No.3)

    Article  Google Scholar 

  6. Sethi S, Gore MT, Sethi KK (2007) Increased sensitivity of direct fluorescent antibody test for legionella pneumophila in bronchoalveolar lavage samples by immunomagnetic separation based on BioMags. J Microbiol Methods 70(2):328–335. https://doi.org/10.1016/j.mimet.2007.05.006

    Article  CAS  PubMed  Google Scholar 

  7. (2019) Tecfidera (dimethyl fumarate) [prescribing information]. Biogen Idec Inc, Cambridge, MA

  8. Yukitake M (2018) Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: a comprehensive review. Clin Exp Neuroimmunol 9(1):37–47. https://doi.org/10.1111/cen3.12440

    Article  CAS  Google Scholar 

  9. Khatri B, Garland J, Berger J et al (2015) The effect of dimethyl fumarate (TecfideraTM) on lymphocyte counts: a potential contributor to progressive multifocal leukoencephalopathy risk. Mult Scler Relat Disord 4(4):377–379. https://doi.org/10.1016/j.msard.2015.05.003

    Article  PubMed  Google Scholar 

  10. Rae-Grant A, Day GS, Marrie RA et al (2018) Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of neurology. Neurology 90(17):789–800. https://doi.org/10.1212/WNL.0000000000005345

    Article  PubMed  Google Scholar 

  11. Epstein DJ, Dunn J, Deresinski S (2018) Infectious complications of multiple sclerosis therapies; implications for screening, prophylaxis, and management. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofy174

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kappos L, Gold R, Miller DH et al (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372(9648):1463–1472

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA, 02139, USA

    Charlotte Rastas & Lou Ann Bruno-Murtha

  2. Department of Pharmacy, Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA, 02139, USA

    David Sirignano & Amanda Barner

Authors
  1. Charlotte Rastas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Sirignano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amanda Barner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lou Ann Bruno-Murtha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charlotte Rastas.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any studies involving human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rastas, C., Sirignano, D., Barner, A. et al. Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis. J Neurol 266, 2867–2868 (2019). https://doi.org/10.1007/s00415-019-09483-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-019-09483-x

Search

Navigation